Step Therapy

This comment letter adddresses S. 3480/S. 2824, which among other things, limits the use of step therapy in the small group market.

PCMA concerns with HF 3854, a prohibition of step therapy for antiretroviral drugs

A veto request of LD 1754, which sets new regulations on prior authorizations for contraceptives.

PCMA submits a comment letter regarding AID proposed rule 107, which seeks to impose new requirements on step therapy protocols for insurers

PCMA submits testimony addressing concerns with SB 1115, a bill to provide coverage for HIV prevention drugs at the lowest cost share. PCMA supports the